NCT07685691

Brief Summary

Stroke-related hemiplegia may be accompanied by peripheral nerve conduction abnormalities, which may contribute to motor impairment and functional limitations. However, the frequency of these abnormalities and their relationship with clinical status have not been fully characterized. This single-center observational study aims to evaluate the frequency of peripheral nerve conduction abnormalities identified by nerve conduction studies in patients with unilateral hemiplegia and to examine their association with motor and functional clinical assessment scores. The findings may contribute to a better understanding of peripheral nerve involvement in stroke rehabilitation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2026

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

June 29, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 6, 2026

Completed
Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

1.6 years

First QC Date

June 29, 2026

Last Update Submit

July 28, 2026

Conditions

Keywords

nerve conduction studyElectrophysiologyFugl-Meyer AssessmentRehabilitation

Outcome Measures

Primary Outcomes (1)

  • Association Between Peripheral Nerve Conduction Abnormalities and Clinical Assessment Scores

    To evaluate the association between peripheral nerve conduction abnormalities identified by standardized nerve conduction studies and motor and functional outcome measures in patients with unilateral hemiplegia secondary to ischemic or hemorrhagic stroke. Peripheral nerve conduction abnormalities identified by standardized nerve conduction studies will also be described.

    Baseline

Secondary Outcomes (4)

  • Fugl-Meyer Assessment (FMA) Score (Upper and Lower Extremities)

    Baseline

  • Functional Independence Measure (FIM) Score

    Baseline

  • Timed Up and Go Test (TUG)

    Baseline

  • Tetrax Fall Index

    At study enrollment (baseline)

Study Arms (1)

Patients With Unilateral Post-Stroke Hemiplegia

Patients with unilateral post-stroke hemiplegia who underwent standardized nerve conduction studies and clinical assessments, including motor and functional outcome measures.

Diagnostic Test: Nerve Conduction Study

Interventions

Nerve Conduction StudyDIAGNOSTIC_TEST

Standardized motor and sensory nerve conduction studies were performed to evaluate peripheral nerve conduction abnormalities in patients with unilateral post-stroke hemiplegia. The test was used as a diagnostic assessment and was not part of a therapeutic intervention.

Also known as: NCS
Patients With Unilateral Post-Stroke Hemiplegia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with unilateral hemiplegia secondary to ischemic or hemorrhagic stroke who were recruited from the Department of Physical Medicine and Rehabilitation at a single tertiary care center. All participants underwent standardized nerve conduction studies and clinical assessments according to the study protocol.

You may qualify if:

  • Adults (≥18 years of age).
  • Unilateral hemiplegia secondary to ischemic or hemorrhagic stroke, or intracranial hemorrhage.
  • Ability to undergo standardized nerve conduction studies and clinical assessments.
  • Provision of written informed consent.

You may not qualify if:

  • Bilateral hemiplegia.
  • Hemiplegia secondary to benign or malignant intracranial tumors.
  • Upper or lower extremity fracture, amputation, skin lesions preventing electrophysiological testing, or diagnosed peripheral vascular disease.
  • Concomitant neurological disorders that may affect motor function or peripheral nerve conduction (e.g., Parkinson's disease, multiple sclerosis, encephalitis).
  • Contraindications to nerve conduction studies (e.g., cardiac pacemaker or inability to safely undergo the examination).
  • Inability to cooperate with or tolerate nerve conduction studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Başkent University Adana Dr. Turgut Noyan Application and Research Center

Adana, 01250, Turkey (Türkiye)

Location

MeSH Terms

Conditions

StrokeHemiplegiaIntracranial Hemorrhages

Interventions

Nerve Conduction Studies

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHemorrhagePathologic Processes

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2026

First Posted

July 6, 2026

Study Start

October 4, 2024

Primary Completion

May 20, 2026

Study Completion

June 24, 2026

Last Updated

July 29, 2026

Record last verified: 2026-07

Locations